Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREGCOVAC-19 follow-up of pregnant women vaccinated against COVID-19
NL-OMON51101Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Amsterdam University Medical Center. Primary endpoint: Maternal and transplacental IgG antibody response. Started Jun 2021; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON51101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51101.